Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
HPV Infection: full-pipeline trial registry
7 of 14 indexed HPV Infection trials are currently recruiting.
Corpus placement: #1,230 of 28,707 conditions by registered trial count.
14 US clinical trials · 7 currently recruiting · #1,230 of 28,707 conditions by registered trial count
HPV Infection: 14 US clinical trials tracked, 7 recruiting.
HPV Infection is the subject of 14 registered US clinical trials on ClinicalTrials.gov, 7 of them currently open to new participants. 4 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Frantz Viral Therapeutics, running 3 of these trials.
Enrollment posture brief
Registry condition hpv-infection
OPEN 7 | RECR 50% | LATE 4 | EARLY 4 | RANK #1230 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
HPV Infection lists 7 open slots (50% of 14 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for HPV Infection on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
HPV Infection is recruiting above its size-band peers.
7 of 14 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates HPV Infection research.
Frantz Viral Therapeutics accounts for 3 of 14 trials (21.4%). 11 distinct sponsors appear on at least one study for this condition label.
-
Typical HPV Infection enrolment sits around 120 participants.
Median target enrolment is 120 among the 14 trials that report a genuine target (sentinel values excluded). 6 of those (42.9%) plan for fewer than 100 participants.
-
HPV Infection research is mostly interventional.
13 interventional and 1 observational studies make up this index (92.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
14 total, page 1 of 1
Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)
The University of Texas Medical Branch, Galveston
NCT05672927
Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
Qurasense
NCT07281599
Feasibility of HPV Testing With Mail-delivered Sample Collection Kits
University of California, San Francisco
NCT07087145
PopSci CHW4CervixHealth
Thomas Jefferson University
NCT07336134
PCOM2 - The Physician Communication Intervention, Version 2.0
University of Colorado, Denver
NCT05336240
Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)
Frantz Viral Therapeutics
NCT04098744
Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)
Frantz Viral Therapeutics
NCT06075264
SELF-CERV Pivotal Study: SELF-Collection for CERVical Cancer Screening
Teal Health
NCT06120205
An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen
Boston Medical Center
NCT04206813
Game-Based Intervention to Promote HPV Vaccination
Michigan State University
NCT06162676
Immunogenicity of Fractional Dose of the HPV Vaccines
University of Washington
NCT05291871
Intradermal, Fractional Dose of HPV Vaccines:
University of Washington
NCT04235257
Early Phase Clinical Trial About Therapeutic Biological Product Mix for Treating HPV
Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair
NCT06959563
Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSIL
Frantz Viral Therapeutics
NCT05555862
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 3 |
| Phase 4 | 4 |
Top Sponsors
Named interventions
Most-linked intervention names on HPV Infection records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on HPV Infection trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this HPV Infection page
14 registered trials, 7 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 7 HPV Infection trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Frantz Viral Therapeutics sponsors the most HPV Infection trials on record, review their full trial history before evaluating a specific study. See Frantz Viral Therapeutics's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This HPV Infection condition card totals 14 registered trials; most-linked intervention HPV vaccine; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.